Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 229

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 229
---
i, LP (“3i”) and may be deemed to be beneficially owned by Maier Tarlow, Manager of 3i. Maier Tarlow disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (34) | Excludes, for beneficial ownership purposes, 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (35) | The reported securities are held directly by Alta Partners, LLC (“Alta Partners”) and may be deemed to be beneficially owned by Stephen Cohen, Managing Member of Alta Partners. Stephen Cohen disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (36) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (37) | The reported securities are held directly by Warberg WF XII LP (“Warberg WF”) and may be deemed to be beneficially owned by Daniel Warsh, Manager of Warberg WF. Daniel Warsh disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (38) | Excludes, for beneficial ownership purposes, 30,024 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (39) | The reported securities are held directly by Warberg Special Situations Fund LP (“WSSF”) and may be deemed to be beneficially owned by Daniel Warsh, Manager of WSSF. Daniel Warsh disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (40) | Excludes, for beneficial ownership purposes, 30,024 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (41) | Excludes, for beneficial ownership purposes, 490,565 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025 and (ii) 75,472 shares of common stock subscribed for in the Offering, but to be purchased by Thomas Mollick on or before December 31, 2025 pursuant to the terms of the Securities Purchase Agreement, dated as of June 2, 2025, between TuHURA and Thomas Mollick